Project Grant HT9425261E066
Award Date 9/15/26
Completion Date 9/14/30
Dollars Obligated $3.3M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Detroit, MI 48202, USA
Similar Awards
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Henry Ford Health System a $292,260 Project Grant effective July 1, 2025, through June 30, 2028, under the Military Medical Research and Development program (CFDA 12.420). The grant supports research titled "Finding the Missing Link Between Pancreatic Neoplasia and Carcinoma," to be conducted at the organization's Detroit, Michigan location. This award funds biomedical research aimed at advancing...
- Federal Project Grant Award Summary Henry Ford Health System received a $620,000 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded September 30, 2025, with a completion date of September 29, 2027. The award funds the development of plasmacytoid dendritic cell (DC) exosomes as a novel cancer vaccine platform designed to overcome CDC1 (conventional dendritic cell type 1) dependence and address tumor...
- Federal Project Grant Award Summary Henry Ford Health System received a $714,934 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period July 1, 2025 through June 30, 2028. The research initiative, titled "Finding the Missing Link Between Pancreatic Neoplasia and Carcinoma," is designed to advance understanding of pancreatic cancer development and progression through biomedical research aimed at...
- This $911,999 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research by the Henry Ford Health System in Detroit, Michigan to target mitochondrial metabolism in ovarian cancer. The award, effective April 1, 2024 through March 31, 2028, will support basic, translational, and clinical research aimed at developing new treatments, diagnostic tools, and preventive measures for this area of military medical importance....
- This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program provides $532,000.00 in funding to the Henry Ford Health System in Detroit, MI. The grant supports research to investigate HDAC3 as a potential therapeutic target for Langerhans cell histiocytosis, a rare medical condition. The performance period for this grant runs from December 1, 2024 to November 30, 2027. As a prominent non-profit...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded a $1.7 million Project Grant to the Regents of the University of Michigan for the period July 1, 2026 through June 30, 2029, under the Military Medical Research and Development program (CFDA 12.420). The project, titled "Targeted Disruption of the ARP300 Enhanceosome in Prostate Cancer Using Domain-Alteration Chimeras (DALTACs)," funds basic and applied biomedical research designed to investigate novel...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded the Regents of the University of Michigan a $2.1M Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support the development of antibody CBP/P300 degrader conjugates for the treatment of castration-resistant prostate cancer. The award, effective June 1, 2026 through May 31, 2030, funds basic and applied biomedical research conducted at the University of Michigan's Ann Arbor campus....
- The Henry Ford Health System was awarded a $615,782 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 15, 2022 to July 14, 2025 to investigate paracrine pathways contributing to the growth and invasion of neurofibromas and the role of the cellular microenvironment. Through this research, the awardee aims to advance understanding of medical solutions for neurofibromas,...
- Federal Project Grant Award Summary Wayne State University received a $319,601 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective November 1, 2025 through October 31, 2027. The award supports research investigating the effects of biological versus chronological aging on mobility and cognition in multiple sclerosis patients. This research initiative aligns with the DHA's mission to transform healthcare for service...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $559,046 to the Regents of the University of Michigan through the Military Medical Research and Development program (CFDA 12.420) for a two-year project investigating biased protein phosphatase 2A (PP2A) heterotrimerization in the development and treatment of uveal melanoma. The award, effective June 1, 2026 through May 31, 2028, supports basic and applied biomedical research addressing medical conditions relevant to...